|
1
|
Cao LL, Lu J, Lin JX, Zheng CH, Li P, Xie
JW, Wang JB, Chen QY, Lin M, Tu RH and Huang CM: Incidence and
survival trends for gastric neuroendocrine neoplasms: An analysis
of 3523 patients in the SEER database. Eur J Surg Oncol.
44:1628–1633. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chauhan A, Yu Q, Ray N, Farooqui Z, Huang
B, Durbin EB, Tucker T, Evers M, Arnold S and Anthony LB: Global
burden of neuroendocrine tumors and changing incidence in Kentucky.
Oncotarget. 9:19245–19254. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dasari A, Shen C, Halperin D, Zhao B, Zhou
S, Xu Y, Shih T and Yao JC: Trends in the incidence, prevalence,
and survival outcomes in patients with neuroendocrine tumors in the
United States. JAMA Oncol. 3:1335–1342. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fraenkel M, Faggiano A and Valk GD:
Epidemiology of neuroendocrine tumors. Front Horm Res. 44:1–23.
2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hallet J, Law CH, Cukier M, Saskin R, Liu
N and Singh S: Exploring the rising incidence of neuroendocrine
tumors: A population-based analysis of epidemiology, metastatic
presentation, and outcomes: Neuroendocrine tumor epidemiology.
Cancer. 121:589–597. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Basuroy R, Bouvier C, Ramage JK, Sissons
M, Kent A and Srirajaskanthan R: Presenting symptoms and delay in
diagnosis of gastrointestinal and pancreatic neuroendocrine
tumours. Neuroendocrinology. 107:42–49. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Basuroy R, Bouvier C, Ramage JK, Sissons M
and Srirajaskanthan R: Delays and routes to diagnosis of
neuroendocrine tumours. BMC Cancer. 18(1122)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
O'Connor JM, Marmissolle F, Bestani C,
Pesce V, Belli S, Dominichini E, Mendez G, Price P, Giacomi N,
Pairola A, et al: Observational study of patients with
gastroenteropancreatic and bronchial neuroendocrine tumors in
Argentina: Results from the large database of a multidisciplinary
group clinical multicenter study. Mol Clin Oncol. 2:673–684.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pinto MP, Muñoz Medel M, Carrillo D,
Retamal IN, Bravo ML, Valenzuela Y, Nervi B, Sánchez C, Galindo H,
Ibañez C, et al: Chilean registry for neuroendocrine tumors: A
Latin American perspective. Horm Cancer. 10:3–10. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rindi G, Arnold R, Bosman FT, Capella C,
Klimstra DS, Klöppel G, Komminoth P and Solcia E: Nomenclature and
classification of neuroendocrine neoplasms of the digestive system.
In: WHO Classification of Tumours of the Digestive System. 4th
edition. WHO Press, Lyon, 2010.
|
|
11
|
Palepu J, Shrikhande SV, Bhaduri D, Shah
RC, Sirohi B, Chhabra V, Dhar P, Sastry R and Sikora S: Trends in
diagnosis of gastroenteropancreatic neuroendocrine tumors
(GEP-NETs) in India: A report of multicenter data from a web-based
registry. Indian J Gastroenterol. 36:445–451. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Maric M, de Haan E, Hogendoorn SM, Wolters
LH and Huizenga HM: Evaluating statistical and clinical
significance of intervention effects in single-case experimental
designs: An SPSS method to analyze univariate data. Behav Ther.
46:230–241. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
United Nations, Department of Economic and
Social Affairs, Population Division. World Population Prospects,
2019. [cited 2020 Dec 6]. Available from: https://population.un.org/wpp/.
|
|
14
|
Modlin IM, Oberg K, Chung DC, Jensen RT,
de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA,
Krenning EP, et al: Gastroenteropancreatic neuroendocrine tumours.
Lancet Oncol. 9:61–72. 2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Instituto Nacional de Estadística y
Censo-Panamá: Estimación de la población total en la República, por
provincia y comarca indígena, según sexo y grupos de edad: Al 1 de
julio de, 2018. Available from: https://www.inec.gob.pa/publicaciones/Default3.aspx?ID_PUBLICACION=990&ID_CATEGORIA=17&ID_SUBCATEGORIA=45.
|
|
16
|
Korse CM, Taal BG, van Velthuysen ML and
Visser O: Incidence and survival of neuroendocrine tumours in the
Netherlands according to histological grade: Experience of two
decades of cancer registry. Eur J Cancer. 49:1975–1983.
2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kourie HR, Ghorra C, Rassy M, Kesserouani
C and Kattan J: Digestive neuroendocrine tumor distribution and
characteristics according to the 2010 WHO classification: A single
institution experience in lebanon. Asian Pac J Cancer Prev.
17:2679–2681. 2016.PubMed/NCBI
|
|
18
|
Caplin ME, Baudin E, Ferolla P, Filosso P,
Garcia-Yuste M, Lim E, Oberg K, Pelosi G, Perren A, Rossi RE, et
al: Pulmonary neuroendocrine (carcinoid) tumors: European
neuroendocrine tumor society expert consensus and recommendations
for best practice for typical and atypical pulmonary carcinoids.
Ann Oncol. 26:1604–1620. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Dias AR, Azevedo BC, Alban LBV, Yagi OK,
Ramos MFKP, Jacob CE, Barchi LC, Cecconello I, Ribeiro U Jr and
Zilberstein B: Gastric neuroendocrine tumor: Review and update. Arq
Bras Cir Dig. 30:150–154. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lee L, Ito T and Jensen RT: Prognostic and
predictive factors on overall survival and surgical outcomes in
pancreatic neuroendocrine tumors: Recent advances and
controversies. Expert Rev Anticancer Ther. 19:1029–1050.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Al-Risi ES, Al-Essry FS and Mula-Abed WS:
Chromogranin A as a biochemical marker for neuroendocrine tumors: A
single center experience at royal hospital, Oman. Oman Med J.
32:365–370. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kim JY and Hong SM: Recent updates on
neuroendocrine tumors from the gastrointestinal and
pancreatobiliary tracts. Arch Pathol Lab Med. 140:437–448.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jin M, Zhou X, Yearsley M and Frankel WL:
Liver metastases of neuroendocrine tumors rarely show overlapping
immunoprofile with hepatocellular carcinomas. Endocr Pathol.
27:253–258. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liu E, Telem DA, Warner RR, Dikman A and
Divino CM: The role of Ki-67 in predicting biological behavior of
goblet cell carcinoid tumor in appendix. Am J Surg. 202:400–403.
2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
O'Toole D, Grossman A, Gross D, Delle Fave
G, Barkmanova J, O'Connor J, Pape UF and Plöckinger U: Mallorca
Consensus Conference participants; European Neuroendocrine Tumor
Society. ENETS consensus guidelines for the standards of care in
neuroendocrine tumors: Biochemical markers. Neuroendocrinology.
90:194–202. 2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tsai HJ, Wu CC, Tsai CR, Lin SF, Chen LT
and Chang JS: The epidemiology of neuroendocrine tumors in Taiwan:
A nation-wide cancer registry-based study. PLoS One.
8(e62487)2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Edfeldt K, Björklund P, Åkerström G,
Westin G, Hellman P and Stålberg P: Different gene expression
profiles in metastasizing midgut carcinoid tumors. Endocr Relat
Cancer. 18:479–489. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Riihimäki M, Hemminki A, Sundquist K,
Sundquist J and Hemminki K: The epidemiology of metastases in
neuroendocrine tumors. Int J Cancer. 139:2679–2686. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Klimstra D, Kloppell G, La Rosa S and
Rindi G: Classification of neuroendocrine neoplasms of the
digestive system. In: WHO Classification of Tumours: Digestive
System Tumours. 5th edition. WHO Classification of Tumours
Editorial Board (Ed), International Agency for Research on Cancer,
Lyon, pp16, 2019.
|
